Cite
HARVARD Citation
Ishida, Y. et al. (2020). Cardiovascular safety and effectiveness of vildagliptin in patients with type 2 diabetes mellitus: a 3-year, large-scale post-marketing surveillance in Japan. Expert opinion on drug safety. 19 (5), pp. 625-631. [Online].